Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.

× No keyword cloud information.

19 in total

1. Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.

Authors: S Kanamitsu; K Ito; C E Green; C A Tyson; N Shimada; Y Sugiyama
Journal: Pharm Res Date: 2000-04 Impact factor: 4.200

Review 2. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors: K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal: Clin Pharmacokinet Date: 2000-02 Impact factor: 6.447

3. Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.

Authors: Annika Allqvist; Jun Miura; Leif Bertilsson; Rajaa A Mirghani
Journal: Eur J Clin Pharmacol Date: 2007-01-03 Impact factor: 2.953

4. A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction.

Authors: Menggang Yu; Seongho Kim; Zhiping Wang; Stephen Hall; Lang Li
Journal: J Biopharm Stat Date: 2008 Impact factor: 1.051

Review 5. Inhibition and induction of cytochrome P450 and the clinical implications.

Authors: J H Lin; A Y Lu
Journal: Clin Pharmacokinet Date: 1998-11 Impact factor: 6.447

6. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.

Authors: Abdul Naveed Shaik; Barbara W LeDuc; Ansar A Khan
Journal: Eur J Drug Metab Pharmacokinet Date: 2017-10 Impact factor: 2.441

7. Effect of Benifuuki Tea on Cytochrome P450-mediated Metabolic Activity in Rats.

Authors: Takahito Hirai; Yuki Nishimura; Norimitsu Kurata; Hokuto Namba; Mariko Iwase; Yurika Gomi; Hiromichi Tsuchiya; Tomoyuki Yamakawa; Yuji Kiuchi
Journal: In Vivo Date: 2018 Jan-Feb Impact factor: 2.155

8. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.

Authors: T Prueksaritanont; B Ma; C Tang; Y Meng; C Assang; P Lu; P J Reider; J H Lin; T A Baillie
Journal: Br J Clin Pharmacol Date: 1999-03 Impact factor: 4.335

Review 9. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.

Authors: Siamak Cyrus Khojasteh; Saileta Prabhu; Jane R Kenny; Jason S Halladay; Anthony Y H Lu
Journal: Eur J Drug Metab Pharmacokinet Date: 2011-02-19 Impact factor: 2.441

10. Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.

Authors: Rajaa A Mirghani; Orjan Ericsson; Gunnel Tybring; Lars L Gustafsson; Leif Bertilsson
Journal: Eur J Clin Pharmacol Date: 2003-03-11 Impact factor: 2.953